Zhejiang Jiaoke: the amount of newly signed orders in the first quarter was 9.488 billion yuan, and the order stock was sufficient

Chassis Supply Chain's "iPhone Moment": China's Tier 1 Shift as LeeKr Emerges

Over the past decade, China's electric vehicle (EV) industry has evolved from a niche experiment into a leading force in the global automotive landscape. In the first ten months of 2025, China exported over 2 million EVs, nearly double the year-earlier figure. From European city streets to Southeast Asian highways and Latin American urban centers, Chinese EVs have emerged as one of the most prominent symbols of a new era of “Made in China.”

Chery (奇瑞) Partners with NVIDIA to Deepen "Physical AI" Strategy, Entering L4 Autonomous Driving and Robotics Tracks

On April 23, Chery Automobile officially announced a global strategic partnership with NVIDIA in Beijing. The two parties will focus on the core framework of "Physical AI" to engage in full-stack technical co-creation across three major fields: assisted driving, cockpit AI, and embodied intelligent robotics.

Chinese auto giant Changan Automobile (长安汽车) unveils 2030 "1445" strategy, partnering with Chinese tech leader Desay SV (德赛西威) for global intelligence synergy

On April 21, Changan Automobile Group (长安汽车集团) held its Global Strategy Launch and Global Partners Conference in Chongqing, officially releasing its "1445" global strategy for 2030. The core vision of this strategy is to build a world-class automotive group with global core competitiveness.

Chinese tech giant Huawei and Vietnam’s SHB Bank enter strategic partnership to accelerate penetration into SE Asia's financial cloud market

On April 22, Saigon-Hanoi Commercial Joint Stock Bank (SHB) of Vietnam officially announced the signing of a strategic cooperation agreement with Chinese tech giant Huawei. Under the agreement, Huawei will be deeply involved in SHB’s technical architecture design, assisting in the construction of its core data platform and providing comprehensive operational stability and security assurance.

CTTQ, Ampsourcebio Ink Agreement on Cure for NASH, T2DM

There are more than 95 plus major players and more than 90 plus nonalcoholic steatohepatitis (NASH) pipeline therapies, but none of them has been approved for marketing. Who would survive the competition in the blue-ocean market for NASH?